KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Other Operating Expenses: 2009-2025

Historic Other Operating Expenses for Arbutus Biopharma (ABUS) over the last 10 years, with Sep 2025 value amounting to $268,000.

  • Arbutus Biopharma's Other Operating Expenses fell 22.09% to $268,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 178.79%. This contributed to the annual value of $2.6 million for FY2024, which is 3704.35% up from last year.
  • Per Arbutus Biopharma's latest filing, its Other Operating Expenses stood at $268,000 for Q3 2025, which was up 19.11% from $225,000 recorded in Q2 2025.
  • In the past 5 years, Arbutus Biopharma's Other Operating Expenses registered a high of $1.9 million during Q4 2024, and its lowest value of -$636,000 during Q2 2023.
  • Over the past 3 years, Arbutus Biopharma's median Other Operating Expenses value was $227,000 (recorded in 2023), while the average stood at $316,909.
  • Per our database at Business Quant, Arbutus Biopharma's Other Operating Expenses surged by 733.68% in 2022 and then tumbled by 405.77% in 2023.
  • Quarterly analysis of 5 years shows Arbutus Biopharma's Other Operating Expenses stood at $193,000 in 2021, then skyrocketed by 733.68% to $1.6 million in 2022, then crashed by 85.89% to $227,000 in 2023, then skyrocketed by 732.60% to $1.9 million in 2024, then fell by 22.09% to $268,000 in 2025.
  • Its Other Operating Expenses stands at $268,000 for Q3 2025, versus $225,000 for Q2 2025 and $299,000 for Q1 2025.